Liver Function Tests (LFTs) Explained: Interpretation & Patterns | Clinical Medicine

Added:

The Misnomer of 'Liver Function Tests' and the Shift to Quantitative Functional Assays

Traditional 'Liver Function Tests' (LFTs) are widely criticized by clinical experts as a misnomer, because standard panels (such as ALT, AST, and ALP) primarily detect hepatocyte damage or biliary obstruction rather than actual metabolic or synthetic liver function. Critics argue that relying on these static, indirect enzyme markers often leads to diagnostic errors, over-investigation of benign fluctuations, or missed early-stage liver dysfunction. Instead, an alternative paradigm advocates for quantitative functional assays—such as the Indocyanine Green (ICG) clearance test, the LiMAx test, or advanced metabolomic profiling. These dynamic assessments measure the liver's actual capacity to metabolize substances in real-time, providing a more accurate evaluation of functional reserve, particularly in surgical planning and critical care, where static LFT patterns fail to predict actual hepatic performance.

Basic anatomy and histology of the liver, including the cellular structure of hepatocytes and the organization of the biliary tree.
The biochemical pathway of bilirubin metabolism, including conjugation in the liver and excretion via bile.
The physiological role of the liver in synthetic function, specifically the synthesis of plasma proteins like albumin and clotting factors.
Fundamental understanding of cellular enzymes (specifically AST, ALT, ALP, and GGT) and what their release into the bloodstream signifies pathologically.
Differential diagnosis of specific liver diseases based on LFT patterns, such as alcoholic hepatitis, viral hepatitis, and drug-induced liver injury (DILI).
Advanced diagnostic workup for abnormal LFTs, including viral serologies, autoimmune markers, and iron overload panels.
The role of hepatobiliary imaging (e.g., abdominal ultrasound, MRCP, ERCP) in investigating cholestatic LFT patterns.
Application of liver synthetic function markers in clinical scoring systems, such as the Child-Pugh classification and the MELD score for end-stage liver disease.
245.3K views7.8Klikes1:22:27@NinjaNerdOfficialOriginal Release: 2024-03-11

Liver Function Tests (LFTs) assess hepatic function and injury through specific enzyme and bilirubin markers: AST and ALT indicate hepatocellular injury (elevated in drug toxicity, viral hepatitis, ischemia, or metabolic diseases); ALP, GGT, and conjugated bilirubin indicate cholestasis (intrahepatic or extrahepatic obstruction); while unconjugated bilirubin elevation suggests hemolysis, Gilbert's syndrome, or rifampin effects. Diagnostic interpretation requires analyzing AST/ALT ratios, bilirubin fractions, and clinical context to distinguish between different mechanisms of liver damage.